This study will investigate how sleep and mood are related in patients with depression and in healthy controls. It will use MRI-based measures of brain function to determine how neural systems are modulated by sleep and sleep deprivation, and its links to mood in depression.
The purpose of this work is to identify brain networks that underlie sleep and mood using a combination of EEG and fMRI. Sleep deprivation can elicit rapid improvements in mood in some patients with depression, while some patients do not show any significant changes in mood. We will image the brain while measuring physiological and electrical signals in healthy individuals and in patients with depression. Subjects will participate in combined EEG-MRI studies that will involve the use of perceptual and attentional tasks, and will involve recording physiological variables such as breathing, heart rate, eye movements, and blood pressure. If combined EEG-MRI cannot be completed due to data quality reasons, subjects will participate in EEG or MRI alone. Subjects will participate in a blood draw to assess for inflammatory markers related to mood. Subjects will be either well-rested or sleep deprived. For sleep deprivation, subjects will be asked to stay awake overnight under the supervision of a member of the study team at Boston University, and then would be asked to do an fMRI, EEG, or EEG-MRI scan. fMRI studies will be performed at the Boston University Center for Cognitive Neuroimaging. During the study visit, subjects will answer questions in structured interviews, will fill out questionnaires that will contain questions related to their mental health. Subjects will be shown visual stimuli and/or listen to auditory stimuli, and/or asked to perform simple behavioral tasks related to these stimuli. Some of the visual stimuli will be emotionally salient. Wrist actigraphy will be used to monitor sleep behavior. Remote daily mood and sleep assessments will be performed for up to two weeks prior to imaging. These assessments will be sent as emails or text messages to participants.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
60
Overnight sleep deprivation.
Boston University
Boston, Massachusetts, United States
RECRUITINGChange in fMRI signals in thalamus region of interest (ROI) from baseline to post intervention
fMRI signal (units: %)
Time frame: Through study completion (approximately 1 month)
Change in fMRI signals in amygdala ROI from baseline to post intervention
fMRI signal (units: %)
Time frame: Through study completion (approximately 1 month)
Change in tasked evoked responses in amygdala ROI from baseline to post intervention
Task evoked responses in amygdala ROI (units: %)
Time frame: Through study completion (approximately 1 month)
Change in cerebrospinal fluid (CSF) flow measurements from baseline to post intervention
Fluid flow measured with MRI (units: %)
Time frame: Through study completion (approximately 1 month)
Change in Montgomery-Asberg Depression Rating from baseline to post intervention
Mood scores, measured on scale of 0-60
Time frame: Through study completion (approximately 1 month)
Change in whole-brain voxelwise fMRI activity from baseline to post intervention
fMRI measure of hemodynamics (units: %)
Time frame: Through study completion (approximately 1 month)
Change in EEG dynamics from baseline to post intervention
Amplitude of EEG signals (units: uV\^2)
Time frame: Through study completion (approximately 1 month)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in dot probe task performance from baseline to post intervention
Behavior on emotional task (units: ms)
Time frame: Through study completion (approximately 1 month)
Change in blood biomarkers of C-reactive protein from baseline to post intervention
Blood analysis results (units: mg/L)
Time frame: Through study completion (approximately 1 month)
Change in blood levels of Interleukin 6 from baseline to post intervention
Measured in pg/mL
Time frame: Through study completion (approximately 1 month)
Change in Magnetic Resonance Spectroscopy (MRS) measurement of lactate from baseline to post intervention
MRS measure of lactate (units: i.u.)
Time frame: Through study completion (approximately 1 month)
Change in MRS measurement of myo-inositol from baseline to post intervention
Magnetic Resonance Spectroscopy measure of myo-inositol (units: i.u.)
Time frame: Through study completion (approximately 1 month)
Change in Positive and Negative Affect Scale 21 (PANAS-21) rating from baseline to post intervention
The Positive and Negative Affect Scale (PANAS-21) assess positive and negative affect using scales relating to how participants feel about certain words.
Time frame: Through study completion (approximately 1 month)
Change in Positive and Negative Affect Scale 21 (PANAS-21) rating during intervention
The Positive and Negative Affect Scale (PANAS-21) assess positive and negative affect using scales relating to how participants feel about certain words.
Time frame: Throughout intervention (approximately 17 hours)
Change in Shame Inventory rating from baseline to post intervention
The Shame Inventory assess participants' feelings related to shame. Units: scale.
Time frame: Through study completion (approximately 1 month)
Change in Shame Inventory rating during intervention
The Shame Inventory assess participants' feelings related to shame. Units: scale.
Time frame: Throughout intervention (approximately 17 hours)
Change in Anxiety Sensitivity Index (ASI-3) rating from baseline to post intervention
The Anxiety Sensitivity Index assess participants' concern related to anxiety.Units: scale.
Time frame: Through study completion (approximately 1 month)
Change in Anxiety Sensitivity Index (ASI-3) rating during intervention
The Anxiety Sensitivity Index assess participants' concern related to anxiety.Units: scale.
Time frame: Throughout intervention (approximately 17 hours)
Change in Depression, Anxiety, and Stress Scale (DASS-21) rating from baseline to post intervention
The Depression, Anxiety, and Stress Scale assesses participants emotional states. Units: scale.
Time frame: Through study completion (approximately 1 month)
Change in Depression, Anxiety, and Stress Scale (DASS-21) rating during intervention
The Depression, Anxiety, and Stress Scale assesses participants emotional states. Units: scale.
Time frame: Throughout intervention (approximately 17 hours)
Patient health questionnaire (PHQ-9)
This patient health questionnaire is used to compute a general depression score.Units: scale.
Time frame: Pre-enrollment